The bispecific B7H3xCD3 antibody CC-3 induces T cell immunity against bone and soft tissue sarcomas
Sarcomas are rare and heterogeneous malignancies that are difficult to treat.Approximately 50% of patients diagnosed with sarcoma develop metastatic disease with so far very limited treatment options.